Rationale and Objectives: Pulmonary nodules can be missed on the non-breath hold computed tomography (CT) portion of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT), and for this reason prior studies have advocated for routinely performing dedicated breath hold CT of the chest in addition to PET/CT for routine staging of malignancy. We evaluated the rate of pulmonary nodule detection on standard CT images from whole body PET/CT studies (WB-PET/CT), high-resolution lung reconstruction CT images from PET/CT studies (HR-PET/CT), and diagnostic breath hold chest CT (BH-CT).
INTRODUCTION

1
8F-Fluorodeoxyglucose (FDG) positron emission tomography combined with whole body computed tomography (PET/CT) has become the standard of care imaging test for staging of patients with non-small cell lung cancer (NSCLC) (1) . Staging of NSCLC is performed using the tumor, node, metastasis (TNM) classification system (2) (3) (4) (5) . Multiple prior studies have demonstrated that PET/CT is superior to CT alone for staging the primary mass (T stage) (6) , associated nodal disease (N stage) (7) , and distant metastasis (M stage) (8) . For these reasons, PET/CT has become widely used for this application.
The presence or absence of pulmonary nodules, distinct from the primary mass, is an important contributor to the overall stage of NSCLC (3) (4) (5) . Specifically, the presence of other nodules in the same lobe as the primary tumor confers the T3 stage, and the presence of nodules in the same side, different lobe, results in a T4 tumor. Metastatic pulmonary nodules in the contralateral lung confer M1a disease. An accurate assessment for nodules suggestive of metastatic disease can only be accomplished via imaging; therefore, it is critical to accurately assess the presence of even small pulmonary nodules.
Several investigators have previously investigated the ability of PET/CT to detect pulmonary nodules, and compared against conventional breath hold chest CT (BH-CT) (9) (10) (11) (12) . Overall, these studies have found that small pulmonary nodules can be missed on PET/CT in comparison with conventional CT, because of the non-breath-hold technique on PET/CT, as well as the low spatial resolution of the CT component of the examination (including generally thick slices and lower in-plane resolution with large fields of view). Furthermore, small pulmonary nodules below 1 cm in size are often not seen on the PET portion of the examination (13, 14) . This has led some authors to conclude that PET/CT is insufficient to completely stage malignancies because of the missed nodules (10) (11) (12) . In most routine PET/CT scans, the images are reconstructed using a relatively thick slices (typically 5 mm), with soft tissue reconstruction algorithm. Prior studies have demonstrated that using thinner slices (1.25 mm) can improve the rate of pulmonary nodule detection on routine BH-CT (15) . At our institution, we commonly reformat CT images from PET/CT studies with a high-resolution reconstruction to improve the detection of pulmonary nodules, although the added value from these reformations is unknown.
The objective of this study was to assess the ability to detect pulmonary nodules on high-resolution reformatted CT images compared to standard CT images obtained as part of whole body PET-CT (WB-PET/CT) studies. Although it is likely that improved resolution should yield some improvement in nodule detection, this has not been previously investigated in the PET/CT context. We compared the ability to detect nodules on both sets of images to that of diagnostic BHCTs. We hypothesized that the high-resolution reformats would reveal more nodules than the standard CT images from WB-PET/CT, and that the increased sensitivity would be similar to those obtained via dedicated chest CT studies.
METHODS
Patient Selection
This retrospective study was approved by our institution's institutional review board (IRB) and informed consent was waived. We searched our database of all PET/CT performed between February 2012 and July 2013 at our institution for the presence of the term "lung cancer." Scans of patients who met the following inclusion criteria were included up to our target enrollment of 25 patients: Lung reformation CT images were generated using 2-mm slice thickness and a sharp reconstruction algorithm. PET was performed immediately following CT, without patient repositioning. PET images were obtained in 3D mode at 7-10 bed positions per patient, with an acquisition time of 3-4 minutes per station, from the skull vertex through the mid-thigh. BH-CT examinations were performed on 16-or 64-slice General Electric Lightspeed VCT scanners, at a kVp of 120 with auto-mAs. Images were reconstructed as contiguous 1.25-mm transaxial slices using standard chest CT reconstruction algorithms that were optimized for both lung and soft tissue evaluation (the degree of edge enhancement was in between that used for abdominal CTs and those used for high resolution computed tomography (HRCT)s to evaluate for interstitial lung disease). A portion of the BH-CT was performed with contrast: 70-150 mL of Omnipaque 350.
Imaging and Chart Review
The medical charts of patients included in the study were reviewed for demographic data and histologic confirmation of diagnosis. All cases were reviewed independently for the presence of pulmonary nodules by three radiologists with 4, 9, and 9 years of CT experience. One reader was a radiology resident with 3 years experience, one was an abdominal imaging and nuclear medicine with 9 years of CT experience, and fellowship training in abdominal imaging and nuclear medicine, and one was a thoracic radiology and nuclear medicine with 9 years of CT experience, and fellowship training in thoracic radiology and nuclear medicine. Each reader reviewed the three sets of images of all 25 patients, thereby resulting in 75 reviewed studies. The order the studies were reviewed was randomized and divided into three separate blocks of 25 examinations. Each set of 25 examinations was reviewed separately, and all examinations were reviewed over a course of 3 months. All examinations were interpreted for the presence of pulmonary nodules, which were defined using standard criteria: discrete, rounded opacities between 3 and 30 mm in diameter. Nodules with definitively benign imaging characteristics, such as dense uniform calcification or macroscopic fat (16), were excluded. The location of all nodules was recorded, as was the size (longest dimension on transaxial CT images). The total number of nodules was summed up for both the right and left lungs for each reader, scan type, and patient. The quality of the scan for detecting pulmonary nodules was assessed using a qualitative scale from 1 to 10, where 1 is poor or nondiagnostic and 10 is optimal in technique.
Statistical Analysis
Statistical analysis was performed with MedCalc for Windows, version 14.8.1 (MedCalc Software, Ostend, Belgium). Twoway repeated measures analysis of variance (ANOVA) was used to evaluate the differences in the number of nodules detected by modality and reader. This was repeated for nodules less than or equal to 8 mm and for nodules greater than 8 mm. Two-way repeated measures ANOVA was also used to evaluate the differences in quality rating between modality and reader. As the datasets were not perfectly normally distributed, in order to ensure that results were not driven by deviations from the underlying assumptions of ANOVA, the analyses were repeated after a rank transformation to achieve a more normal distribution. The statistical significance of comparisons was not significantly changed, and thus the more easily understood non-rank-transformed results are presented. Generally, P < 0.05 was used to signify statistical significance, although for pairwise comparisons in which three statistics were available, a Bonferroni correction was applied; therefore, P < 0.05/3 = 0.0167 was considered statistically significant.
RESULTS
Patient Demographics
Patient demographics are summarized in Table 1 . Sixteen of the 25 BH-CTs were performed with intravenous contrast (64%), as well as all of the PET/CTs (25/25; 100%).
Scan Interpretation
WB-PET/CT, high-resolution PET/CT (HR-PET/CT), and BH-CT were interpreted for the presence and size of nodules, as outlined in the Methods section. Three representative cases are shown in Figure 1 .
When averaged across the three readers, 69.3, 96.3, and 97.7 nodules were found across 25 patients on WB-PET/CT, HR-PET/CT, and BH-CT, respectively. Overall, this yields 2.77 nodules per patient on WB-PET/CT, 3.85 nodules per patient on HR-PET/CT, and 3.91 nodules per patient on BH-CT (statistical analyses for differences are reported in the next section). When only nodules less than or equal to 8 mm in size were considered, an average of 1.98, 2.94, and 2.86 nodules were found per patient on WB-PET/CT, HR-PET/CT, and BH-CT, respectively. When nodules greater than 8 mm were considered, an average of 1.04, 0.99, and 0.85 nodules were found on BH-CT, HR-PET/CT, and WB-PET/CT, respectively. The results analyzed on a per-reader basis are shown in Figure 2 .
Each reader analyzed each scan for overall quality, with a rating ranging from 1 to 10, where 1 is nondiagnostic and 10 is optimal for detection of pulmonary nodules. These results are summarized in Figure 3 . When averaged across all three readers, the average quality score for WB-PET/CT was 7.36, for HR-PET/CT it was 8.43, and for BH-CT it was 8.81 (statistical analysis for differences is reported in the following section).
Statistical Analysis
For nodules of all sizes, two-way repeated measures ANOVA was statistically significant for differences in the mean number of nodules by modality (F = 11.78, P < 0.001) but not statistically significantly different by reader (F = 0.028, P = 0.927). For pairwise comparisons between modalities, there was a statistically significant difference between WB-PET/CT and HR-PET/CT (P < 0.001), and a statistically significant difference between WB-PET/CT and BH-CT (P < 0.001). There was no statistically significant difference between HR-PET/CT and BH-CT (P = 0.9181).
For the smallest nodules, those less than 8 mm, a twoway repeated measures ANOVA was statistically significant for differences in the mean number by modality (F = 8.74, P < 0.001) but not by reader (F = 0.17, P = 0.846). Pairwise comparisons again demonstrated a statistically significant difference between WB-PET/CT and the two higher resolution modalities (P < 0.001, for comparisons of BH-CT and HR-PET/CT), but not between the two higher resolution modalities (P = 0.754).
When nodules greater than 8 mm in size were considered, two-way repeated measures ANOVA was not statistically PET/CT, positron emission tomography/computed tomography.
Academic Radiology, Vol 23, No 9, September 2016 PULMONARY NODULE DETECTION ON PET/CT significant for differences in the mean number of nodules >8 mm by modality (F = 2.24, P = 0.110) or by reader (F = 0.78, P = 0.461). Two-way repeated measures ANOVA was statistically significant for differences in the mean quality rating by modality (F = 51.72, P < 0.001) and by reader (F = 31.05, P < 0.001). Pairwise differences revealed reader #3 differed in the use of the scoring system from the other two (mean score given was 9.09, compared to 7.73 and 7.77, respectively; P < 0.001). There was no statistically significant difference in ratings between readers #1 and #2 (P = 0.839). Pairwise differences in quality by modality demonstrated a statistically significant difference between WB-PET/CT and BH-CT (P < 0.001), a statistically significant difference between WB-PET/CT and HR-PET/CT (P < 0.001), and a statistically significant difference between HR-PET/CT and BH-CT (P = 0.011).
DISCUSSION
The presence or absence of pulmonary nodules identified on imaging can affect staging, and therefore management, in patients with NSCLC and other malignancies. The objective of this study was to evaluate the relative performance of three diagnostic methods for detecting pulmonary nodules, including standard CT images from WB-PET/CT, HR-PET/CT, and BH-CT. The key new finding in our study is that HR-PET/CT is superior in the detection of pulmonary nodules to standard CT images from WB-PET/CT studies and indistinguishable from that of BH-CT. Readers also qualitatively rated high-resolution reformatted images as higher than standard images, approaching the ratings of BH-CT images.
We have not identified any prior studies directly assessing the performance of high-resolution CT images from PET/CT studies for detecting pulmonary nodules. Many studies, however, have demonstrated that BH-CT is superior to standard WB-PET/CT images. Several studies have demonstrated that pulmonary nodules are missed on WB-PET/CT, in comparison to BH-CT, ranging from 0.56 to 0.88 nodules per patient (9) (10) (11) (12) . In our study, 29 nodules were missed in 25 patients, for an average of 1.16 nodules per patient. This slight increase from previous reports may be because of the greater overall prevalence of pulmonary nodules in our study population. In comparison to other studies, we reviewed exclusively NSCLC patients, whereas other studies included many different malignancies. Furthermore, our study was conducted in a region with high levels of endemic coccidioidomycosis and a high prevalence of benign nodules (17) . Taken together, our data are consistent with the previously described reports and confirm the finding that WB-PET/CT is inferior to BH-CT for detection of pulmonary nodules.
In detecting pulmonary nodules, WB-PET/CT is inferior in comparison to BH-CT for two reasons. First, the CT portion of PET/CT cannot be performed with a maximal inspiration because of the attenuation correction and misregistration artifacts that would result (18) , instead it is typically performed in a neutral breath hold. Second, there is lower in-plane resolution because of the large field of view in order to include the shoulders as well as low z-axis resolution, which allows the whole body to be covered in a manageable number of images. In our study, high-resolution reformations of the lungs allow for nodule detection similar to BH-CT; the performance of these reformats appears to be due to the improved special resolution in the z-axis (2 mm vs 5 mm) and the use of an edge-enhancing algorithm that simulates an improved in-plane resolution (Fig 1) . This technique optimizes the properties of the CT for pulmonary nodule detection without giving additional radiation dose.
Although no prior reports could be located assessing high-resolution reformats of the lung as part of PET/CT scans, high-resolution targeted images of the neck have been shown to improve the accuracy of staging of head and neck squamous cell cancer (19) . Unlike this previously reported technique, which requires an additional scan, our The primary limitation of our study is that we were not able to directly assess the clinical significance detecting additional nodules with this technique. First, we were not able to determine in this retrospective analysis whether the additionally detected nodules were benign or malignant; many prior studies, however, have shown that a reasonable minority of detected nodules in lung cancer patients are indeed malignant, including some nodules detectable by higher resolution techniques that were missed by PET/CT. In a study of 551 patients with lung cancer who had a staging BH-CT, 11% of small noncalcified pulmonary nodules were malignant (20) . In a pathologically verified study of 65 pulmonary nodules 1 cm or smaller, 58% were malignant (21) . In a second pathologically verified study of 160 nodules of less than or equal to 0.5 cm resected at surgery, 58% were malignant (22) . In a study incorporating patients with a variety of malignancies, Thipphavong et al. found that 6 of 159 (3.7%) nodules missed on PET/CT but found on BH-CT were malignant lesions (9). Kim et al. (23) found that 6 of 138 nodules (4.3%) in NSCLC patients in the non-primary cancer lobe were malignant.
Second, on the new malignant nodules that could be detected, we could not assess via this study the ultimate importance of finding such nodules with regard to altering management or staging. Such a study would require a large number of patients and high-level longitudinal follow-up. That said, many prior investigators have concluded that BH-CT should be performed in addition to WB-PET/CT for staging of malignancies (10) (11) (12) ; these HR reformats approximate BH-CT in the accuracy of detecting nodules and may be a sufficient substitute in some cases.
This study has a few additional smaller limitations. First, we studied a small patient cohort, which was necessary given the multiple reads required for each patient; we nonetheless were able to detect a statistically significant difference between the modalities. Potentially a larger sample could have resulted in identifying a small difference between HR-PET/CT and BH-CT, although the difference is not likely to be clinically significant. Second, the study is limited because of its retrospective design. Third, the CT technique in the BH-CT group used reconstruction algorithms that were optimized for both lung and soft tissue evaluation, and it is possible that a true edge-enhancing reconstruction algorithm may have detected additional pulmonary nodules. Finally, given that we did not detect differences in readers' sensitivities, we could not evaluate the factors that could have been associated with a greater or lesser ability to detect nodules.
Our data indicate that HR reformations from PET/CT images are superior for the detection of pulmonary nodules compared to standard PET/CT images, and are overall similar to diagnostic BH-CTs. To our knowledge, we are the first to demonstrate that HR-PET/CT improves pulmonary nodule detection, and specifically to a level indistinguishable from routine BH-CT, which is widely recommended in the staging of multiple malignancies. It is likely that HR-PET/CT obviates the need for dedicated BH-CT for the detection of pulmonary nodules. Similarly, we have demonstrated that the quality score of such high-resolution reformats was higher than for standard WB-PET/CT images. HR-PET/CT is a simple intervention that requires no additional scan time or radiation and can easily be incorporated into routine clinical practice.
